cmv/adv specific t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2009 (NCT00880789)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- unidentified adenovirusImmunity, passive
unidentified adenovirus immunity, passive
- CytomegalovirusImmunity, passive
Cytomegalovirus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cmv/adv specific t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02851576 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2011 | University of Bordeaux, University of Lorraine |
| NCT00880789 | Phase 1 | May 1, 2009 | Baylor University, Methodist Cancer Center, Houston, Texas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Bordeaux | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Lorraine | Academic/Hospital | 1 | 1 | 1 | 2011 |
4 organizations
Page 1 / 1